14th Marzo 2023
Comunicati stampa
Scopri tutto su i nostri comunicati stampa recenti, resta aggiornato sulle ultime notizie e informati sui prossimi eventi a cui Curium parteciperà.
2nd Marzo 2023
Innovation and growing demand for nuclear medicine drives Curium expansion and 10-year commitment to St. Louis, MO
21st Dicembre 2022
Curium’s 14 million patients to benefit from regular supply of Mo-99 and TC-99
24th Novembre 2022
Curium’s Customers to benefit from Mo-99 Production restart
22nd Novembre 2022
Curium Announces New Indication for Ioflupane I 123 Injection in the U.S.
9th Novembre 2022
Nuclear Medicine Outlook: Proven Molybenum-99 Supply Chain Reliability and New Planned Capacity Continue to Benefit Patients
18th Agosto 2022
NRG and Curium Sign Multi-Year Isotope Production Contract
27th Giugno 2022
Curium Announces The Submission Of Its Marketing Authorization Application For [18F]-DCFPyL To The European Medicines Agency
12th Maggio 2022
Curium Confirms No Supply Challenges of 177Lu-PSMA-I&T for ECLIPSE Trial
3rd Maggio 2022
Curium’s Phase 3 ECLIPSE Trial Starts Enrolling Patients
19th Aprile 2022
Curium Announces Significant Increase in Detectnet™ (copper Cu 64 dotatate injection) Production Capacity
5th Aprile 2022
Curium Announces FDA Approval of a Generic Version of DaTscan™ (Ioflupane I 123 Injection) in the U.S.
25th Gennaio 2022
Curium to become major player in the supply on non carrier added Lu-177
15th Dicembre 2021
Curium is pleased to announce that Sakir Mutevelic MD, MSc has joined as global Chief Medical Officer
27th Ottobre 2021
Curium Initiates ECLIPSE, a Phase 3 Clinical Trial For Its Investigational Lu 177 PSMA I&T
24th Agosto 2021
Curium Announces Submission of an Investigational New Drug (IND) Application for Cu-64 PSMA I&T
1st Giugno 2021
Curium Acquires Austrian Radiopharmaceuticals Company IASON
5th Maggio 2021
RadioMedix & Curium Announce Detectnet™ (copper Cu 64 dotatate injection) Inclusion on NCCN Guidelines®
4th Maggio 2021
Curium Announces Filing of a Generic Version of DaTscan™ (Ioflupane I 123 Injection) in the U.S.
28th Aprile 2021